BECKMAN COULTER LIFE SCIENCES TO LAUNCH NEW PRODUCT VIA LIVE STREAMING EVENT

After visiting labs around the world to identify ways to advance its industry-leading cell counting technology, Beckman Coulter Life Sciences will host a live streaming event on March 26 at 10 a.m. EDT / 7 a.m. PDT to announce its latest product innovation.

What:

After visiting labs around the world to identify ways to advance its industry-leading cell counting technology, Beckman Coulter Life Sciences will host a live streaming event on March 26 at 10 a.m. EDT / 7 a.m. PDT to announce its latest product innovation. The event will show biopharma scientists, process engineers, and others in labs who work with cells how the new product will enhance bioprocess systems and offer a glimpse into the future of cell viability analysis.

During the live event, product manager Lena Lee will provide an in-depth look at the highly-anticipated product, followed by a live Q&A session. Viewers will also get an exclusive look at the tradeshows and conferences where Beckman Coulter Life Sciences will showcase this new technology.

Media are invited to register for the event at Beckman.com/live

Who:

Lena Lee, product manager for Beckman Coulter Life Sciences

When:

Tuesday, March 26, 2019

10 a.m. EDT / 7 a.m. PDT

Where:

Beckman.com/live

For additional questions, please contact:

Emily Edeburn, Global Commercial Marketing Manager for Particle Characterization and Counting

(317) 646-2172

eeedeburn@beckman.com

About Beckman Coulter Life Sciences

Beckman Coulter Life Sciences develops, manufactures and markets products that simplify, automate and innovate complex biomedical testing. For more than 75 years, our products have been making a difference in peoples' lives by improving the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. Scientists use our life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs.

For more information, visit beckman.com. Follow Beckman Coulter Life Sciences on Twitter @BCILifeSciences; Facebook: https://www.facebook.com/BCILifeSciences and LinkedIn.

 
 
 
 
 
 
MORE ON THIS TOPIC